Pharmacotherapies for Alcoholism: Promising Agents and Clinical Issues
- 1 August 1991
- journal article
- review article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 15 (4) , 620-633
- https://doi.org/10.1111/j.1530-0277.1991.tb00570.x
Abstract
The past 10 years have witnessed important advances in research on pharmacotherapy for alcoholism. Promising drugs are discussed under six headings: agents to treat alcohol withdrawal; anticraving agents; agents that make drinking an aversive experience; agents to alleviate concomitant psychiatric problems; agents to treat concurrent drug abuse; and amethystic (“sobering‐up”) agents. Research on the drug classes is summarized and clinical issues surrounding specific agents and alcoholism pharmacotherapy in general are discussed. Finally, long‐range therapeutic implications of recent findings on the actions of alcohol on basic mechanisms of the brain are offered.Keywords
This publication has 160 references indexed in Scilit:
- Attenuation of ethanol intoxication by alpha-2 adrenoceptor antagonistsLife Sciences, 1989
- Alcohol and SeizuresNew England Journal of Medicine, 1988
- Forskolin promotes the development of ethanol tolerance in 6-hydroxydopamine-treated miceLife Sciences, 1988
- Calcium channel antagonists decrease the ethanol withdrawal syndromeLife Sciences, 1986
- Naltrexone blocks the post-shock increase of ethanol consumptionLife Sciences, 1986
- Randomized Clinical Trial of Atenolol in Patients with Alcohol WithdrawalNew England Journal of Medicine, 1985
- A comparison of disulfiram acceptors and refusers on selected demographic and clinical characteristicsDrug and Alcohol Dependence, 1984
- Zimelidine effects on memory impairments produced by ethanolLife Sciences, 1983
- Structural requirements for neurohypophyseal peptide maintenance of ethanol tolerancePharmacology Biochemistry and Behavior, 1982
- Benzodiazepines attenuate single unit activity in the locus coeruleusLife Sciences, 1980